🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic Surgery

Recruitingn/aAges 18 Years - 85 YearsAllDr Abdurrahman Yurtaslan Ankara Oncology Training…
NCT07100860 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study investigates the relationship between the duration of single-lung ventilation (SLV) and the incidence of postoperative pulmonary complications (PPCs) such as pneumonia, pneumothorax, hemothorax, acute lung injury, and acute respiratory distress syndrome (ARDS) in adult patients undergoing thoracic surgery. A total of 134 patients aged 18-85 years, scheduled for thoracic surgery requiring SLV, will be monitored. Data including SLV duration, perioperative parameters, and postoperative pulmonary outcomes will be analyzed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Age ≥18 years Undergoing thoracic surgery OLV planned during the procedure Exclusion Criteria: Pediatric patients Patients not requiring OLV Previous thoracic surgery
💊

What it tests

  • One-Lung ventilation
📍

Where

1 site
Hazal Ekin GÜRAN AYTUĞ
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy